Liu Y - Search Results

1

Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis.

Wu S, Ma X, Zhang X, Du K, Shi C, Almaamari AA, Han B, Su S, Liu Y. Wu S, et al. Among authors: liu y. Cancer Biol Ther. 2025 Dec;26(1):2445220. doi: 10.1080/15384047.2024.2445220. Epub 2024 Dec 20. Cancer Biol Ther. 2025. PMID: 39706687 Free PMC article.

2

Hsa_circ_0002496 promotes the growth, angiogenesis, and stemness of breast cancer cells via miR-433-3p/YWHAZ cascade.

Yang C, Zhang S, Liu L, Zhang X, Du K, Gao C, Li J, Liu Y. Yang C, et al. Among authors: liu y, liu l. Thorac Cancer. 2023 Jun;14(18):1732-1741. doi: 10.1111/1759-7714.14918. Epub 2023 May 9. Thorac Cancer. 2023. PMID: 37160403 Free PMC article.

3

Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study.

Du KY, Wu S, Ma X, Liu Y. Du KY, et al. Among authors: liu y. Breast Cancer Res Treat. 2024 Oct;207(3):517-527. doi: 10.1007/s10549-024-07430-7. Epub 2024 Jul 11. Breast Cancer Res Treat. 2024. PMID: 38990453

4

Prognostic Value of LRG1 in Breast Cancer: A Retrospective Study.

Zhang YS, Han L, Yang C, Liu YJ, Zhang XM. Zhang YS, et al. Oncol Res Treat. 2021;44(1-2):36-42. doi: 10.1159/000510945. Epub 2020 Nov 26. Oncol Res Treat. 2021. PMID: 33242858

5

NRBP1 negatively regulates SALL4 to reduce the invasion and migration, promote apoptosis and increase the sensitivity to chemotherapy drugs of breast cancer cells.

Yang C, Zhang X, Gao C, Du K, Liu Y. Yang C, et al. Among authors: liu y. Oncol Lett. 2022 Apr;23(4):139. doi: 10.3892/ol.2022.13259. Epub 2022 Mar 2. Oncol Lett. 2022. PMID: 35317026 Free PMC article.

6

The expression landscape of FOXP3 and its prognostic value in breast cancer.

Li J, Zhang X, Liu B, Shi C, Ma X, Ren S, Zhao X, Liu Y. Li J, et al. Among authors: liu y, liu b. Ann Transl Med. 2022 Jul;10(14):801. doi: 10.21037/atm-22-3080. Ann Transl Med. 2022. PMID: 35965804 Free PMC article.

7

Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis.

Zhang W, Wu S, Liu J, Zhang X, Ma X, Yang C, Cao M, Zhang S, Liu Y. Zhang W, et al. Among authors: liu j, liu y. Front Oncol. 2022 Oct 13;12:872862. doi: 10.3389/fonc.2022.872862. eCollection 2022. Front Oncol. 2022. PMID: 36313697 Free PMC article.

8

Survival outcomes of autologous breast reconstruction after mastectomy: A matched case-control study.

Wu S, Ma X, Zhang X, Yang C, Wang Y, Liu Y. Wu S, et al. Among authors: liu y. Front Oncol. 2023 Jan 6;12:1022925. doi: 10.3389/fonc.2022.1022925. eCollection 2022. Front Oncol. 2023. PMID: 36686843 Free PMC article.

9

PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity.

Du R, Zhang X, Lu X, Ma X, Guo X, Shi C, Ren X, Ma X, He Y, Gao Y, Liu Y. Du R, et al. Among authors: liu y. Drug Resist Updat. 2023 May;68:100947. doi: 10.1016/j.drup.2023.100947. Epub 2023 Feb 9. Drug Resist Updat. 2023. PMID: 36812747

10

Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway.

Chen NN, Ma XD, Miao Z, Zhang XM, Han BY, Almaamari AA, Huang JM, Chen XY, Liu YJ, Su SW. Chen NN, et al. Front Pharmacol. 2023 Jul 19;14:1150861. doi: 10.3389/fphar.2023.1150861. eCollection 2023. Front Pharmacol. 2023. PMID: 37538178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,607 results

Search Page

Filters